These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 3914115)

  • 1. Drug-resistant malaria--changing patterns mean difficult decisions.
    Spencer HC
    Trans R Soc Trop Med Hyg; 1985; 79(6):748-58. PubMed ID: 3914115
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of chloroquine, amodiaquine and pyrimethamine-sulfadoxine on Plasmodium falciparum gametocytemia.
    Strickland GT; Fox E; Sarwar M; Khaliq AA; Macdonald M
    Am J Trop Med Hyg; 1986 Mar; 35(2):259-62. PubMed ID: 3513644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to treatment in man of multi-drug resistant Plasmodium falciparum from Panama.
    Glew RH; Miller LH; Collins WE; Howard WA; Wyler DJ; Chaves-Carballo E; Neva FA
    Am J Trop Med Hyg; 1974 Jan; 23(1):1-7. PubMed ID: 4204024
    [No Abstract]   [Full Text] [Related]  

  • 4. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology of the antimalarials. A rational approach to the therapy of resistant falciparum malaria.
    Hunsicker LG
    Arch Intern Med; 1969 Jun; 123(6):645-9. PubMed ID: 4890439
    [No Abstract]   [Full Text] [Related]  

  • 6. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
    Ghosh SK; Yadav RS; Sharma VP
    Indian J Malariol; 1992 Dec; 29(4):211-8. PubMed ID: 1291342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Falciparum malaria resistant to chloroquine, quinine and Fansidar in a non-immune patient infected in Ghana.
    Nguyen C; Gregson D; Mouldey P; Keystone JS
    Trans R Soc Trop Med Hyg; 1989; 83(4):485-6. PubMed ID: 2694485
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.
    Kamugisha J; Kipp W; Burnham G
    Trop Geogr Med; 1994; 46(6):364-5. PubMed ID: 7892705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance of Plasmodium falciparum to 3 antimalarials in Turbo (Antioquia, Colombia), 1998].
    Blair S; Lacharme LL; Fonseca JC; Tobón A
    Rev Panam Salud Publica; 2001 Jan; 9(1):23-9. PubMed ID: 11253274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia.
    Espinal CA; Cortes GT; Guerra P; Arias AE
    Am J Trop Med Hyg; 1985 Jul; 34(4):675-80. PubMed ID: 3895999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, pyronaridine and sulfadoxine/pyrimethamine in south Yunnan].
    Yang H; Yang P; Yang Y
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1994; 12(2):140-2. PubMed ID: 7955166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia.
    Baird JK; Basri H; Jones TR; Purnomo ; Bangs MJ; Ritonga A
    Am J Trop Med Hyg; 1991 Jun; 44(6):640-4. PubMed ID: 1858967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria prophylaxis for Canadian travellers.
    CMAJ; 1985 Nov; 133(10):1024-6. PubMed ID: 3904965
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo efficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania.
    Gorissen E; Ashruf G; Lamboo M; Bennebroek J; Gikunda S; Mbaruku G; Kager PA
    Trop Med Int Health; 2000 Jun; 5(6):459-63. PubMed ID: 10929148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of amodiaquine in uncomplicated falciparum malaria in Nigeria in an area with high-level resistance to chloroquine and sulphadoxine/pyrimethamine.
    Graupner J; Göbels K; Grobusch MP; Lund A; Richter J; Häussinger D
    Parasitol Res; 2005 Jun; 96(3):162-5. PubMed ID: 15864651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical view of the biology of Plasmodia.
    Altstatt LB
    Ann Intern Med; 1969 Jan; 70(1):130-4. PubMed ID: 4884380
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
    Del Nero L; Lamizana L; Pietra V; Nebié I
    Parassitologia; 1994 Dec; 36(3):287-93. PubMed ID: 7637999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the chemoresistance of Plasmodium falciparum in Africa: current data].
    Nguyen-Dinh P
    Ann Soc Belg Med Trop; 1985; 65 Suppl 2():105-13. PubMed ID: 3907528
    [No Abstract]   [Full Text] [Related]  

  • 20. Pyrimethamine-sulfadoxine (Fansidar) resistance in a non-immune Kenyan--a case report.
    Nevill CG; Gardner A
    East Afr Med J; 1991 Feb; 68(2):149-51. PubMed ID: 2040235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.